Olmesartan Medoxomil Macleods

Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomil Macleods, is an angiotensin II receptor blocker presented as a tablet for oral use. It is used to treat high blood pressure, primarily in adult patients. GNH USA supplies Olmesartan Medoxomil Macleods as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan Medoxomil Macleods as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan medoxil is an antihypertensive agent that works on the renin‑angiotensin system to lower blood pressure.

- Hypertension: Helps lower systolic and diastolic blood pressure in adults. - Heart failure: Used as part of combination therapy to improve cardiac output. - Diabetic nephropathy: Reduces proteinuria and slows progression of kidney damage in patients with type 2 diabetes.

Olmesartan medoxil may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Diarrhea - Cough

Serious or Rare Side Effects: - Angio‑anglular S   def def - Hyper‑hyper  t - Liver  t - Kidney  t - Severe hypotension - Acute renal failure

Olmed...

- Monitor  g -   -  g -  g -  d - Store  t - Store at  t -  t -  d -  d -  d -  t -  -  -  -  t -  -  d -  -  -  d -  -  d -  d -  d -  -  d - Store at below 25°C:  t -  -  -  d -  -  -  d -  -  d -  -  -  d -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -